Connected Drug Delivery Devices Market Size and Share 2022-27

The IMARC Group provides extensive analysis of the connected drug delivery devices industry covering the market trends, investment opportunities, growth trends, statistics, and industry prospects. The report offers a comprehensive analysis of the industry, which comprises insights on connected drug delivery devices market size, share, trends, analysis, growth, demand, statistics, and overview. The report also includes competitor and regional analysis, and contemporary advancements in the global market.

Note: We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report. The market is segmented by size and region. The report provides an analysis of the key trends in each sub-segment of the market, along with forecasts at the global and regional level from 2022-2027. The report also includes competitive landscape of major key players in the industry along with emerging trends in the market.

Informed covered in the report:

Historical market data from 2016-2021
CAGR of the market during the forecast period 2022-2027
Detailed information on factors that will drive market growth during the next five years
Precise estimation of the Keyword market size and its contribution to the parent market
Upcoming market trends and changes in consumer behavior
A thorough analysis of the market's competitive landscape and detailed information on key players
Comprehensive details of factors that will challenge the growth of smart meters market key players

Request for a PDF sample of this report: https://www.imarcgroup.com/connected-drug-delivery-devices-market/requestsample

The global connected drug delivery devices market reached a value of US$ 490.9 Million in 2021. Connected drug delivery devices refer to smart wireless electronic systems that are used for administrating various drugs. They are equipped with dose reminders, adherence trackers, sensors, and examining tools to provide instant feedback for personalized patient care. As a result, these devices are commonly used for treating and managing various diseases, such as diabetes, hepatitis C, hypertension, multiple sclerosis, and clinically isolated syndrome.

Connected Drug Delivery Devices Market Trends:

The global market is primarily being driven by the growing importance of preventive care. Furthermore, connected drug delivery devices aid in reducing dosing errors improving, as well as patient adherence and outcomes, which, in turn, is fueling their demand. In addition, the widespread adoption of networked electronic health records (EHR) in hospitals and laboratories is stimulating the market growth. Some of the other factors, including the rising preference for connected devices, the growing prevalence of chronic diseases, and the rising geriatric population, are projected to drive the market growth in the upcoming years. Looking forward, IMARC Group expects the connected drug delivery devices market to reach US$ 2,951.5 Million by 2027, exhibiting a CAGR of 35.6% during 2022-2027.

Checkout Now: https://www.imarcgroup.com/checkout?id=3738&method=1

As the novel coronavirus (COVID-19) crisis takes over the world, we are continuously tracking the changes in the markets, as well as the industry behaviors of the consumers globally and our estimates about the latest market trends and forecasts are being done after considering the impact of this pandemic.

Competitive Landscape with Key Players:

Adherium Ltd.
BioCorp Production
Cohero Health Inc. (AptarGroup Inc.)
Elcam Medical ACS. Ltd
Findair Sp. z o. o.
Merck KGaA
Phillips Medisize (Molex LLC)
Propeller Health (Resmed Inc.)
Teva Pharmaceutical Industries Ltd.
West Pharmaceutical Services Inc.

Market Segmentation:

Breakup by Product:

Connected Sensors
Connected Inhaler Sensors
Connectable Injection Sensors
Integrated Connected Devices
Connected Inhalation Devices
Connected Injection Devices

Breakup by End User:

Hospitals and Healthcare Providers
Homecare

Breakup by Technology:

Bluetooth
NFC
Others

Breakup by Region:

North America (United States, Canada)
Europe (Germany, France, United Kingdom, Italy, Spain, Others)
Asia Pacific (China, Japan, India, Australia, Indonesia, Korea, Others)
Latin America (Brazil, Mexico, Others)
Middle East and Africa (United Arab Emirates, Saudi Arabia, Qatar, Iraq, Others)

Ask Analyst for Customization and Explore full report with TOC & List of Figures: https://www.imarcgroup.com/connected-drug-delivery-devices-market

Key highlights of the report:                                                    

Market Performance (2016-2021)
Market Outlook (2022-2027)
Market Trends
Market Drivers and Success Factors
Impact of COVID-19
Value Chain Analysis
Comprehensive mapping of the competitive landscape

If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.

Contact Us:

IMARC Group

30 N Gould St Ste R

Sheridan, WY 82801 USA - Wyoming

Email: Sales@imarcgroup.com

Tel No:(D) +91 120 433 0800

Americas: - +1 631 791 1145 | Africa and Europe: - +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800

About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC's information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company's expertise.

This release was published on openPR.